Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin Dose-Ranging Study in Type 2 Diabetes
NCT00238498Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vildagliptin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Jul 2004; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00238498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238498.